ホームページへ
820К+ 2014年以降患者がサポートを受けています
50
1,500 クリニック
6K+ レビュー
3K+ 3,000名以上の資格を持つ医師

中国での非ホジキンリンパ腫診断・治療費用について今すぐご確認ください

料金はお問い合わせください
中国トルコオーストリア
骨髄移植術から $55,000から $36,000から $140,000
非血縁者間同種骨髄移植術から $82,000から $80,000から $180,000
自家骨髄移植術から $52,000から $31,500から $50,000
大腸癌に対する放射線療法から $11,500から $7,000から $12,000
同種骨髄移植術から $78,000から $65,000から $150,000
データは2026年May月時点でBookimedにより検証され、世界75件のクリニックからの患者リクエストと公式見積もりに基づいています。中央値費用は実際の請求書(2024年-2026年)に基づいており毎月更新されます。実際の価格は異なる場合があります。

Bookimedでのお客様のメリットと保証

直接価格

Bookimedは非ホジキンリンパ腫治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。

検証済みクリニック・医師のみ

Bookimedはお客様の安全に取り組んでいます。非ホジキンリンパ腫治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。

無料24時間365日サポート

Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。非ホジキンリンパ腫治療の旅路でお一人になることはありません。

なぜ当社を?

Bookimed専属アシスタント

  • すべての段階でサポート
  • 適切なクリニックと医師の選択をサポート
  • 迅速で便利な情報アクセスを確保

中国の最高の非ホジキンリンパ腫クリニックをご発見ください:1件の認証済み選択肢と料金

クリニックはBookimedのスマートシステムにより、5つの主要基準でのデータサイエンス分析を使用してランク付けされています。

中国で非ホジキンリンパ腫の医学評価を受ける:今すぐ経験豊富な医師にご相談ください

すべての医師を見る

このコンテンツを共有

Bookimed患者のビデオストーリー

Dayana
I combined my vacation in Antalya with a check-up.
治療: 女性検査
クリニック: Memorial Antalya Hospital
Igor
It was great! Transfers, accommodation, treatment—all included.
治療: 歯科インプラント
クリニック: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
治療: 女性検査
クリニック: Severance Hospital
更新済み: 05/08/2025
著者
アンナ・レオノヴァ
アンナ・レオノヴァ
コンテンツマーケティングチーム責任者
10年以上の経験を持つ認定医療ライターで、文学修士号を持ち、世界中の医療専門家のインタビューに基づくBookimedの信頼できるコンテンツを開発しています。
Fahad Mawlood
医学編集者・データサイエンティスト
一般開業医。4つの科学賞受賞。西アジアでの勤務経験。アラビア語を話す患者様をサポートする医療チームの元チームリーダー。現在はデータ処理と医療コンテンツの正確性を担当
Fahad Mawlood Linkedin
このページは、さまざまな国で利用可能な各種医療状態、治療、ヘルスケアサービスに関する情報を掲載する場合があります。コンテンツは情報提供のみを目的として提供されており、医療アドバイスやガイダンスとして解釈されるべきではないことをご承知おきください。医療治療を開始または変更する前に、医師または資格のある医療専門家にご相談ください。

中国での非ホジキンリンパ腫治療に関するFAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

What advanced therapies are available for Non-Hodgkin’s Lymphoma in patients treated in China?

China offers advanced therapies for Non-Hodgkin’s Lymphoma, including domestic CAR T-cell treatments like Relma-cel and Axi-cel. Leading centers also utilize bispecific antibodies like glofitamab. Specialized hematopoietic stem cell transplantation remains a primary consolidation therapy for aggressive B-cell and T-cell malignancies.

  • Cellular immunotherapy: CAR-T products target relapsed B-cell lymphoma and mantle cell lymphoma.
  • Targeted inhibitors: Chidamide specifically treats relapsed or refractory peripheral T-cell lymphoma.
  • Transplant options: Specialized hospitals provide autologous and allogeneic stem cell transplants.
  • Bispecific antibodies: New NMPA-approved therapies bridge T-cells to destroy lymphoma cells.

Bookimed Expert Insight: Lu Daopei Hematology Hospital manages an immense volume of 200,000 patients annually. This high frequency allows their 350 doctors to refine complex protocols for refractory cases. The facility maintains 1,300 beds specifically for hematology. This scale ensures deep expertise in managing transplant-related recovery and cellular therapy side effects.

Patient Consensus: Patients note that CAR-T therapy often serves as a powerful last-line option. They emphasize confirming exact molecular markers before choosing between targeted drugs or clinical trials.

How does the standard first-line treatment for the most common aggressive and indolent subtypes compare to Western medical guidelines?

Standard first-line therapy for non-Hodgkin lymphoma in China aligns closely with Western medical guidelines. High-volume centers in Beijing follow NCCN protocols. Aggressive subtypes require immediate chemoimmunotherapy. Indolent subtypes often utilize active surveillance. Both approaches match international standards for efficacy and safety.

  • Aggressive care: Diffuse Large B-Cell Lymphoma receives immediate R-CHOP or Pola-R-CHP therapy.
  • Indolent management: Follicular Lymphoma patients often start with active surveillance for low-burden disease.
  • Advanced options: Facilities offer autologous and allogenic bone marrow transplantation for high-risk cases.
  • Specialized pediatric care: Centers like Beijing Kyoto Children Hospital provide specialized protocols for childhood blood disorders.

Bookimed Expert Insight: Lu Daopei Hematology Hospital manages over 200,000 patients annually. This high volume allows doctors like Dr. Lu Peihua to refine transplant protocols. Large patient cohorts often lead to specialized wards for refractory cases. This infrastructure supports complex procedures like allogenic bone marrow transplants from unrelated donors. These advanced treatments are available when standard first-line therapies do not achieve a full cure.

Patient Consensus: Patients with aggressive lymphoma note that prompt initiation of treatment is critical. Those with slow-growing types feel reassured when doctors explain why waiting and monitoring is a safe, standard choice.

Which hospitals in China have the highest reputation for safely treating Non-Hodgkin’s Lymphoma in international patients?

Lu Daopei Hematology Hospital and Fuda Cancer Hospital are leading institutions for Non-Hodgkin lymphoma in China. These centers excel in cellular immunotherapies and Joint Commission International safety protocols. They manage high volumes of complex cases. Their expertise includes advanced bone marrow transplants and specialized pathology review.

  • Specialized capacity: Lu Daopei Hospital operates 1,300 beds dedicated entirely to blood cancers.
  • Clinical volume: Top centers manage over 200,000 patients annually for hematology-oncology conditions.
  • Safety accreditation: Fuda Cancer Hospital maintains Joint Commission International accreditation for international safety.
  • Expert staffing: Facilities like Lu Daopei employ over 350 specialized doctors for hematology.

Bookimed Expert Insight: While Lu Daopei Hospital is a global leader for bone marrow transplants, its sheer volume of 200,000 annual patients is the best safety indicator. This massive caseload ensures doctors like Dr. Lu Peihua see rare lymphoma subtypes daily. High-volume centers often manage neutropenia and chemotherapy complications more effectively than smaller boutique facilities.

Patient Consensus: Patients note it is important to bring original biopsy blocks for pathology review. They emphasize choosing large academic centers over private hotels to ensure better infection control and ICU access.

What role does Traditional Chinese Medicine play during treatment in China?

Traditional Chinese Medicine (TCM) is a core component of Chinas healthcare system. It integrates with oncology to support conventional treatments for non-Hodgkin lymphoma. Doctors use TCM primarily to manage side effects like fatigue and nausea. It also aims to boost immune function and systemic vitality.

  • Integrated care model: Most general hospitals feature dedicated inpatient Traditional Chinese Medicine departments.
  • Supportive role: Practitioners focus on mitigating side effects from chemotherapy and radiation.
  • Treatment modalities: Care includes herbal formulations, acupuncture, and therapeutic massage for rehabilitation.
  • Symptom management: Therapies target cancer-related fatigue, insomnia, and loss of appetite.

Bookimed Expert Insight: Data shows that hematology centers like Lu Daopei Hematology Hospital maintain huge capacities with 1,300 beds. While these centers focus on advanced modern hematology and bone marrow transplants, their massive size often allows for specialized integrated support. Patients can find doctors like Dr. Xiao Juan who bring extensive experience in managing high-risk blood diseases while navigating these dual-system hospital environments.

Patient Consensus: Patients note that TCM is best used for symptom relief like easing dry mouth or anxiety. Many emphasize that keeping the oncology team informed about all herbal teas is vital. They warn that certain tonics might interfere with chemotherapy or affect liver function during active treatment.

How long should an international patient plan to stay in China for each treatment pathway?

International patients stay in China for 2 to 180 days based on their treatment path. Short diagnostics take 2 to 10 days. Chemotherapy requires multiple short visits or months of care. Complex procedures like CAR-T therapy or transplants require 1 to 6 months for monitoring.

  • Diagnostic phase: Initial workup and pathology verification usually require 2 to 14 days.
  • Chemotherapy cycles: Single sessions are brief, but full regimens often span several months.
  • Radiation therapy: Daily sessions are typically scheduled over a 1 to 6 week period.
  • Intensive cell therapy: CAR-T and bone marrow transplants demand 30 to 180 days stay.

Bookimed Expert Insight: Lu Daopei Hematology Hospital manages 200,000 patients yearly across 30 departments. This massive volume allows their 350 doctors to streamline diagnostics. Patients can often get complex lab results within 48 hours here. This efficiency is vital for lymphoma cases requiring rapid staging before starting intensive therapy.

Patient Consensus: Patients advise bringing original pathology blocks and English summaries to avoid repeat biopsies. Many recommend staying near the clinic for the first cycle to ensure stability before flying home.

How can international patients overcome language barriers when undergoing treatment?

International patients overcome language barriers by using professional medical interpreters and bilingual coordinators for clinical communication. Specialized oncology centers in China provide dual-language documentation for pathology and treatment plans. Using written summaries of medications and dosages reduces risks during complex non-Hodgkin's lymphoma protocols.

  • Professional interpretation: Use certified medical translators for chemo schedules and consent.
  • Bilingual documentation: Carry medical records and pathology reports in English and Chinese.
  • Visual communication: Use anatomical diagrams and symptom scales to describe side effects.
  • Teach-back method: Repeat treatment instructions to doctors to verify complete understanding.

Bookimed Expert Insight: Quality hematology centers like Lu Daopei Hematology Hospital manage over 200,000 patients annually. High-volume hospitals often have established systems for international cases. Choose a facility with a high patient-to-bed ratio to ensure staff are experienced with rapid-response communication in busy environments.

Patient Consensus: Patients note that translation apps work for logistics but fail during critical oncology decisions. They emphasize getting every medication name and dosage in writing to avoid dangerous misunderstandings.

無料相談を受ける

最適な連絡方法をお選びください